StemCells Profile

0.02  1.59%
Trading Day 

StemCells Inc Risk Profiles

Key Fundamentals

StemCells Against Markets

StemCells Leadership

Martin McGlynn CEO, Director, Member of Strategic Transactions Committee, CEO of Stemcells California Inc and President of Stemcells California Inc
John Schwartz Independent Chairman of the Board, Ph.D
More Executives

StemCells Diversification Suggestion

Use StemCells to enhance returns of your portfolios. The stock experiences large bullish trend. Check odds of StemCells to be traded at 1.408 in 30 days
  The entity StemCells Inc with a symbol STEM was delisted from Nasdaq Capital Markets. Please use Microbot Medical Inc with a symbol MBOT from now on.


StemCells Corporate Directors
Alan Trounson Director
Irving Weissman Director
Megan Meloni Director of Investor Relations and Corporate Communications


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


StemCells Earnings Estimates
StemCells Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate